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Background: Early life exposure to inorganic arsenic may be related to adverse health effects in later life. However,
there are few data on postnatal arsenic exposure via human milk. In this study, we aimed to determine arsenic
levels in human milk and the correlation between arsenic in human milk and arsenic in mothers and infants urine.
Methods: Between March 2011 and March 2012, this prospective study identified a total of 120 new mother-baby
pairs from Kashiani (subdistrict), Bangladesh. Of these, 30 mothers were randomly selected for human milk samples
at 1, 6 and 9 months post-natally; the same mother baby pairs were selected for urine sampling at 1 and 6 months.
Twelve urine samples from these 30 mother baby pairs were randomly selected for arsenic speciation.
Results: Arsenic concentration in human milk was low and non-normally distributed. The median arsenic
concentration in human milk at all three time points remained at 0.5 μg/L. In the mixed model estimates,
arsenic concentration in human milk was non-significantly reduced by −0.035 μg/L (95% CI: −0.09 to 0.02)
between 1 and 6 months and between 6 and 9 months. With the progression of time, arsenic concentration in
infant’s urine increased non-significantly by 0.13 μg/L (95% CI: −1.27 to 1.53). Arsenic in human milk at 1 and
6 months was not correlated with arsenic in the infant’s urine at the same time points (r = −0.13 at 1 month
and r = −0.09 at 6 month). Arsenite (AsIII), arsenate (AsV), monomethyl arsonic acid (MMA), dimethyl arsinic acid
(DMA) and arsenobetaine (AsB) were the constituents of total urinary arsenic; DMA was the predominant
arsenic metabolite in infant urine.
Conclusions: We observed a low arsenic concentration in human milk. The concentration was lower than the
World Health Organization’s maximum permissible limit (WHO Permissible Limit 15 μg/kg-bw/week). Our
findings support the safety of breastfeeding even in arsenic contaminated areas.
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Chronic arsenic exposure via drinking water has been
considered a serious public health problem in many
countries [1]. More than 100 million people in the
world are chronically exposed to arsenic and nearly
one quarter to one half of this total are living in
Bangladesh [2]. Exposure to this known toxicant and
carcinogen brings about profound adverse health out-
comes in humans [2-5]. Evidence exists for associa-
tions between maternal arsenic exposure and foetal
loss, impaired foetal growth, reduced thymic function
in infants, and increased infant morbidity and mortal-
ity [6,7]. Infants that are solely breastfed showed po-
tential for exposure to heavy metals including arsenic
via breast milk [8] which might increase the risk of ad-
verse health consequences.
Early life and in-utero arsenic exposure in children
and foetuses is a growing concern in terms of develop-
ment of chronic diseases in later life [9,10] and has
drawn increasing attention [11]. Exposure effects includ-
ing windows of exposure in young and school aged chil-
dren have not been investigated adequately [1,12] and it
remains inconclusive whether arsenic is an immediate or
long term health threat to children, infants, babies and
foetuses [13]. It is generally known that exposure to en-
vironmental contaminants during key developmental
stages can cause toxic injury to brain tissue [14]. There
is substantial evidence for having similar concentrations
of arsenic in cord and maternal blood and arsenic can
readily cross the placenta during the late gestational
period [15]; this may cause brain damage in the develop-
ing foetus. This prenatal exposure is found to be associ-
ated with adverse effects in early childhood and both pre
and postnatal exposure can contribute to disease in later
life [16]. There is inconclusive data on the presence and
amount of postnatal exposure to arsenic via breast milk
[7,17] and less information on its metabolism in young
people. Efficient arsenic methylation to dimethyl arsinic
acid (DMA) increases arsenic excretion from the body
which in turn reduces the health risks [18], while higher
monomethylarsonic acid (MMA) content in urine is as-
sociated with increased risk of adverse health outcomes
in adults [19]. It is thus essential to know what amount
of arsenic passes through breast milk to breastfeeding
children living in arsenic contaminated areas. This is
particularly important for assessing the World Health
Organization’s (WHO) policy for exclusive breastfeeding
in infants until 6 months and breastfeeding predominantly
until 9 months [20]. We therefore aimed to detect the
amount of arsenic in human milk of lactating mothers and
relate this to corresponding maternal and children’s
urinary arsenic in arsenic contaminated areas in
Bangladesh; we also aimed to determine the arsenic
species in these samples.Methods
This longitudinal study was conducted over a period of
13 months between March 2011 and March 2012 in
Kashiani Upazila (Sub-district), Gopalgonj, Dhaka,
Bangladesh. The whole Gopalgonj district is arsenic con-
taminated; 94% of ground water samples that were sur-
veyed previously contained arsenic over the permissible
limit of 50 μg/L [21] and the study subdistrict is a known
contaminated area. The subdistrict is situated about 200
kilometers south west of the country’s capital city, Dhaka.
The subdistrict is comprised of 45,170 households with a
total population of 228,647 over 299.64 square kilometres
and is divided into 14 unions. A union is the smallest ad-
ministrative geographical unit of the country. On the basis
of convenience and accessibility, we purposively selected 3
unions initially to recruit eligible participants.
A total of 120 mother-infant pairs were recruited pro-
spectively. Any new, healthy, mother and infant pair who
had lived in the study area for a period of 12 months and
could provide the required information, body measure-
ments and biological samples, was eligible. Of the 120 pro-
spectively selected mother-baby pairs, 30 were randomly
selected and approached to provide human milk samples
at 1, 6 and 9 months postnatal as well as maternal and in-
fant urine samples at 1 and 6 months. Also, from these 30
mother-baby pairs, 12 were randomly selected for urinary
arsenic speciation.
Ethics
Ethical approval was obtained from the Human Research
Ethics Committee (HREC), The University of Newcastle,
Australia (number H-2010-1211). The study also re-
ceived ethical approval from Bangladesh Medical Research
Council (BMRC) (number BMRC/HNPSP/2010-2013/372).
Written informed consent was obtained from all participat-
ing mothers or from the head of the household.
Data collection procedure
Three trained female Field Research Assistants screened
households in the selected unions using a list of pregnant
mothers who would give birth in the following three
month period and who gave birth in the previous one
month period from the day of household visit. The list of
potential pregnant mothers and mother-newborn pairs
was supplied by the FWAs (FWA: Family Welfare Assist-
ant) and supervisors (FPI: Family Planning Inspector,
AFPI: Assistant Family Planning Inspector) of the Ministry
of Health and Family Welfare, Government of Bangladesh.
Since the literacy rate is low in the selected sampling areas
in Bangladesh, the study information sheet was read out
to potential participants, and the objectives and expecta-
tions of the study were comprehensively explained. At
each contact point with the household, the Field Research
Assistants reminded the household members of the
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wells marked with a red colour as these contain arsenic
at or above the WHO (World Health Organization)
safety limit for drinking water for Bangladesh (50 μg/L).
The study information sheet was then left with the po-
tential participants, and after 48 hours they were con-
tacted either via mobile phone or by household visit;
trained field workers then obtained written informed con-
sent from the participating mother or her husband/guard-
ian. Subsequently, Field Research Assistants collected
questionnaire information, obtained biological samples and
performed body measurements of the mother-baby pairs.
Exposure measurement
A single tubewell water measurement and current house-
hold drinking water samples drawn from that well were
used to measure current arsenic exposure for each partici-
pating mother-baby pair following standard procedures
[22]. Water arsenic analyses were performed using con-
tinuous flow hydride generation atomic fluorescence spec-
troscopy (HGAFS). The minimum detection level of
arsenic by this method is 1 μg/L.
Sample collection and preservation
Drinking water
Drinking water samples were collected once only in a
50 ml plastic bottle from each survey household at the
time of initial contact and participant recruitment. The
plastic bottles were pre-acid washed in the NGO forum
for Drinking Water (a leading national Non-Government
Organization) laboratory, Dhaka, Bangladesh. The field
workers pumped out about a litre of water from the tube-
well before collecting water samples in the bottle. The bot-
tle was then sealed tightly with parafilm tape and kept in
an ice box in the field after labelling.
Human milk
Approximately 10 ml of human milk sample was col-
lected from each participating mother at each time point
in prewashed and dried 20 ml plastic containers. The
breast milk samples were collected by the interviewing
field research assistants in a separate closed and or locked
room under adequate privacy. The sampling time points
(1, 6 and 9 months) are transition points for neonate to in-
fant, exclusive breastfeeding to complementary feeding,
and continuing breastfeeding with complementary feed-
ing, respectively. After collection, the containers were
sealed with parafilm tape and preserved in an ice cold box
in the field after labelling.
Urine
Mothers’ and children’s day time urine samples were col-
lected in prewashed and dried 20 ml plastic containers
when the child was 1 and 6 months old. A PUC (paediatricurine collection) bag was attached around the child’s exter-
nal genitalia and the Research Assistants encouraged the
mother to breastfeed her infant. The Research Assistants
waited in the survey household until the child urinated in
the PUC bag and transferred the samples from PUC bag to
the 20 ml plastic container; these were stored in an ice box
in the field following labelling. Upon receipt at the field of-
fice, all samples (water, milk, urine) were stored in a freezer
at −20°C until they were transferred to the reference la-
boratory in the USA for arsenic analysis.
Sample analysis
All the biological samples and drinking water samples were
analysed in the Department of Chemistry Laboratory,
Wagner College, 631 Howard Avenue state island, NY
10301, United States and urinary arsenic speciation was
adjusted by specific gravity.
Arsenic analysis in human milk
Sample digestion
Human milk samples were digested in Ultrex high purity
(99.99% pure) nitric acid HNO3 (J.T. Baker Chemical
Co., USA). An aliquot of 1–2 ml sample was taken in a
polyethylene digestion tube and 3mls of HNO3 were
added to it. In addition, 2 mls of high purity (99.99%
pure) H2O2 were added to the sample. The mixture was
heated in a microwave oven (MARS X, CEM Corpor-
ation., USA) at 180°C at 1600 watt power for 20 minutes,
and cooled for 10 minutes; this cycle was repeated 2
more times. The solution was reduced to approximately
2 mls after heating. The final volume of the solution was
adjusted to 5 ml with ultra-purified (18.2 MΩ) water.
For each batch of sample digestion, a blank was pre-
pared in exactly the same manner with all reagents in
the tube except a sample.
Analytical technique of breast milk
Arsenic (As) analysis in human milk samples was carried
out by graphite furnace atomic absorption spectroscopy
(GF-AAS) (Perkin Elmer, Model Analyst 800) with Zeeman
background correction and high energy electrode-less dis-
charge lamps. The matrix modifier for As analysis consisted
of a solution containing 1% (w/v) Ni(NO3)2▪6H2O and 0.1%
Triton X-100. High purity (99.99%) Ni(NO3)2.6H2O, 2%
(w/v) (Sigma-Aldrich Co., USA) in 18 MΩcm−1 water was
used throughout the analysis.
Calibration standards were prepared fresh daily using
a 1000 mg/l standard As solution (Perkin-Elmer Co.,
USA) and 0.1% Triton X-100 as diluent. For As analysis
the matrix modifier consists of 1% Ni(NO3)2.6H2O
(Sigma-Aldrich Co., USA), 0.1% Triton X-100 (Fisher
Scientific Co., USA). For As analysis, sample and matrix
modifiers are co-injected in the graphite furnace.
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dards were loaded in an auto sampler tray (AS 60) (Perkin-
Elmer Co., USA) in the GF-AAS system. The minimum
detection level with this method was 0.50 μg/l for both
urine and breast milk.
Arsenic analysis in urine samples of mothers and infants
The urine samples were diluted with distilled deionized
water in 1:4 or 1:5 ratio to bring the concentration of ar-
senic within the range of the arsenic calibration curve.
Standard solutions were prepared by diluting 1000 mg/l
stock solution (Perkin-Elmer Co., USA) with control
urine samples collected from laboratory personnel not
exposed to arsenic from drinking water. The matrix
modifier for arsenic analysis in urine sample was a solu-
tion consisting of 1% K2S2O8 and 1% Pd(NO3)2 solution
prepared in 0.10% HNO3. For method validation control
reference samples of SRM 2670 (NIST) and Seronorm
(Sero, Norway) urine samples were analyzed under iden-
tical analysis conditions.
Quality control
The spectrophotometers AAS and AFS were calibrated
everyday with standards prepared from stock 1000 ppm
As solution from Perkin-Elmer Co. (USA). The software
alerts the analyst to any concentration over the calibra-
tion linear range and the sample is subsequently diluted.
The AFS was calibrated in ppb (microgram of arsenic
per liter of water) unit and the concentration of arsenic
in all samples was directly read from the spectrometer.
For quality control (QC), the QC standards and reagent
blanks were analyzed at regular intervals. All standards
and the reagents were prepared fresh daily. Standard refer-
ence materials (SRM 1643d, SRM 1640, SRM 2670) from
the National Institute of Standards and Technology (NIST,
USA) were used as controls for precision and accuracy
checks of data and validation of analytical methods.
Other information
Research Assistants collected information on socio-
demographics, drinking, bathing, washing, cooking, and
history of water use by face to face interview using a struc-
tured questionnaire. Information on postnatal food intake
including use of colostrum, external and or complemen-
tary foods and infectious disease morbidity at 3, 6 and
9 months was also collected.
Statistical analysis
Data were analysed using STATA version 11 supplied by
STATA Corporation, TX, USA. Frequency tables were
obtained to check missing data, out of range values and to
assess distributions of continuous variables. Arsenic con-
centration in drinking water that was collected at initial
contact with the household was categorised as <50 μg/Land ≥50 μg/L since arsenic at 50 μg/L of drinking water is
the maximum permissible limit for Bangladesh, set by the
World Health Organization [21].
Summary statistics including mean, median and ranges
for the arsenic in human milk and in infant’s urine were
presented. Scatter plots were drawn for arsenic concentra-
tion in human milk and urine samples at all the time
points collected. We also performed simple linear regres-
sion analysis. To observe any significant increment or dec-
rement of arsenic concentration in human milk over time
using mixed model estimates in linear regression.
Results
From the 30 randomly selected mother-infant pairs, hu-
man milk samples from 29 mothers at 1 month (23 house-
holds with arsenic at <50 μg/L), 25 mothers at 6 months
(19 households with arsenic at <50 μg/L) and 19 mothers
at 9 months (14 households with arsenic at <50 μg/L)
were available for arsenic analysis. Urine samples from 29
mothers and 29 babies at 1 month, and 27 mothers and 27
babies at 6 months were available for arsenic analysis. Of
these urine samples from both the mother-baby pairs, all
twelve randomly selected samples were available for ar-
senic speciation at 1 and 6 months.
During the initial stage of the study, six (21%) of the
households’ drinking water contained arsenic at ≥50 μg/L.
The study mothers were relatively young with a mean age
of 24.6 years at the time of initial biological sample (hu-
man milk, urine) collection i.e. at 1 month of child’s age.
About 62% (18) of newborns were offered external food or
drink such as normal water, sugar, glucose or crystalline
sugar water, honey, powdered and cow’s milk in the three
days after birth. At 6 months of infant’s age, 10% (3) of the
infants were not on any breastfeeding and 48% (14) had
started feeding with formula milk using spoon. Almost all
the children (97%) were given water and about 41% (12)
were offered fruit juice to drink at 6 months of age. Semo-
lina, sweet foods and eggs were predominantly (62%, 38%
and 34%, respectively) given to the infants at 6 months of
age. Table 1 depicts the characteristics of the participating
mother-infant pairs.
Arsenic concentration in human milk was non-normally
distributed and skewed to the right at each time point of
sample collection. Therefore we performed a non-
parametric Kruskal-Wallis test to see whether there was
any significant difference in human milk arsenic content
according to the household’s drinking water arsenic cat-
egory (<50 μg/L and ≥50 μg/L); we did not find any sig-
nificant difference (P = 0.9, 0.7 and 0.1 at 1, 6 and
9 months, respectively).
Arsenic concentration in human milk at 1, 6 and
9 months ranged from 0.5 to 8.9 μg/L, 0.5 to 2.32 μg/L and
0.5 to 1.68 μg/L, respectively. The median arsenic concen-
tration in human milk at all three time points remained the
Table 1 Demographic and other characteristics of participating mother baby-pairs (N = 29)
Mother Infant
Characteristics Values Range Characteristics Values Range
Age in years at initial survey: 24.6 ± 5.0 18-40 - - -
- - - Child’s gender, n (%):
Male: 15 (51.7) -
Female 14 (48.3) -
- - - Child’s birth wt. in kg : 3.2 ± 0.6 2-4
Missing, n (%): 19 (65.5) -
Religion, n (%): §Given any drink
Muslim: 19 (65.5) - within 72 h of birth, 18 (62.1) -
Hindu: 10 (34.5) - n (%):
Number of pregnancies: 2.5 ± 1.7 1-8 - - -
Number of live births: 2.4 ± 1.6 1-8 - - -
24 h water intake (L): 2.45 ± 1.15 1.25 – 6.5 - - -
Arsenic in water (μg/L): 45.4 ± 71.8 5 - 387 - - -
SES, Wealth index, n (%): Food given in past
1 4 (13.8) - 24 hours at 6
2 3 (10.3) - months, n (%):
3 7 (24.1) - Breast milk -
4 4 (13.8) - Spoon feeding 26 (89.7) -
5 4 (13.8) - Vitamin 14 (48.3) -
Missing 7 (24.1) - Water 03 (10.3) -
Formula milk 38 (96.5) -
Fruit juice 14 (48.3) -
Semolina 12 (41.4) -
Orange coloured food 18 (62.1) -
Eggs 04 (13.8) -
*Sweets 10 (34.5) -
11 (37.9) -
§Normal water, sugar or glucose water, sugar crystals or misri water, honey, powder milk or pure cow’s milk, infant formula milk; *Chocolate, cake, sweets made of
milk product.









1 month of infants
age, (n = 29)
1.12 ± 1.86 0.5 (0.5-8.9) 0.5 – 2.35
6 months of infants
age, (n = 25)
0.78 ± 0.45 0.5 (0.5-2.32) 0.5 – 1.52
9 months of infants
age, (n = 19)
0.70 ± 0.42 0.5 (0.5-1.68) 0.5 – 1.59
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at 1 month, 0.5 – 1.52 μg/L at 6 month and 0.5 – 1.59 μg/L
at 9 months (Table 2).
In the univariate analysis, arsenic excretion via human
milk did not differ by socio-economic status at any time
point except a significant association observed between
lowest and middle asset quintile groups at 1 month of
child’s age (p < 0.05).
In the mixed model estimates, arsenic concentration in
human milk was non significantly reduced between 1 and
6 months and between 6 and 9 months by −0.035 μg/L
(95% CI: −0.09 to 0.02). As time progressed, arsenic con-
centration in children’s urine increased non-significantly
by 0.13 μg/L (95% CI: −1.27 to 1.53).
Median arsenic concentration in infant urine at 1 month
was 9.2 μg/L and 10th - 90th percentiles were 6 μg/L-45 μg/L (Table 3). Median concentration of urinary arsenic
in infants at 6 months was approximately double the
value at 1 month (16.4 μg/L; 10th – 90th percentiles are
6.6 μg/L – 36 μg/L).
Maternal median urinary arsenic concentration at
1 month was 134 μg/L, 10th – 90th percentiles were
Table 3 Arsenic in maternal and infants urine at different time points of measurement
Time point of measurement Mean ± SD, μg/L Median, μg/L (range) 10-90th percentile, μg/L
Maternal urine
1 month of infants age, (n = 29) 154.8 ± 112.5 134 (5.5-432) 25 -330
6 months of infants age, (n = 27) 90.2 ± 59.8 72 (10.4-252) 18 -165
Infants urine 1 month of infants age, (n = 29) 18.1 ± 15.1 9.2 (3–54) 6 - 45
6 months of infants age, (n = 27) 18.8 ± 11.3 16.4 (3–45) 6.6 - 36
Islam et al. Environmental Health 2014, 13:101 Page 6 of 10
http://www.ehjournal.net/content/13/1/10125 μg/L – 330 μg/L. At 6 months, median arsenic con-
centration in maternal urine was 72 μg/L, 10th – 90th
percentiles were 18 μg/L – 165 μg/L (Table 3).
Maternal urinary arsenic was very weakly correlated
with arsenic in human milk at 1 and 6 months of infant’s
age (r = 0.13 and 0.21, respectively). Arsenic in human
milk at 1 and 6 months was not correlated with that of
infant’s urine (r = −0.13 at 1 month and r = −0.09 at
6 month, Figures 1 and 2).
A total of 12 random urine samples at 1 and 6 months
of age of infants were analysed for arsenic speciation. Of
the infants urine samples at 1 month of age, six out 12
urine samples detected trivalent inorganic arsenic i.e. ar-
senite (AsIII) above the applied dilution limit of <0.080U
(Table 4). The median arsenite concentration in infant’s
urine at 1 month of age was 0.71 μg/L (10th – 90th per-
centiles were 0.09 – 15.4 μg/L). At 6 months, ten of the
12 urine samples from the infants contained arsenite
above the detection limit of <0.080U or applied dilution
(Table 5). The median urinary arsenite in infants at
6 months of age was 1.6 (10th – 90th percentiles were
0.33 – 3.7 μg/L).
Five of the 12 infant urine samples contained pentava-
lent inorganic arsenic i.e. arsenate (AsV) above the de-
tection limit of <0.33U or applied dilution at 1 month of
infant’s age. The median arsenate concentration in in-
fant’s urine at 1 month was 1.37 μg/L (10th – 90th per-
centiles were 0.48 – 3.07 μg/L). On the other hand, allFigure 1 Correlation between arsenic in breast milk and arsenic
in urine of children at 1 month of children’s age.12 infantile urine samples contained arsenate above the
detection limit of <0.33U or applied dilution at 6 months.
Median urinary arsenate concentration at 6 months was
0.40 (10th – 90th percentiles were 0.14 – 1.36 μg/L).
As shown in Tables 4 and 5, other urinary arsenic metab-
olites present in infant and maternal urine are monomethyl
arsonic acid (MMA), dimethyl arsinic acid (DMA) and
arsenobetaine (AsB). DMA constitutes the major arsenic
species in urine both at 1 and 6 months. Excretion of DMA
and AsB in infant urine is increased at 6 months compared
to 1 month while it is decreased in maternal urine.
Since we collected drinking water samples from house-
holds at initial contact when we advised them not to use
water from a tubewell that were marked with red colour
and, urine samples at 1 and 6 months of infant’s age there-
fore, we were interested to see whether mean arsenic con-
centration in maternal urine differed by household drinking
water arsenic categories. Mean total maternal urinary ar-
senic concentration was lower at both time points in the
mothers whose household drinking water contained high
arsenic (≥50 μg/L) compared to the household’s drinking
water of the mothers that contain low (<50 μg/L) arsenic.
Mean of urinary arsenic concentrations at 1 month of in-
fant’s age were 168.1 μg/L and 103.6 μg/L in the mothers
whose household drinking water contain <50 and ≥50 μg/L
of arsenic while mean of the urinary arsenic concentrations
at 6 month of infant’s age were 92.7 μg/L and 81.3 μg/L in
the mothers whose household drinking water contain <50Figure 2 Correlation between arsenic in breast milk and arsenic
in urine of children at 6 month of children’s age.
Table 4 Speciation and quantification of arsenic in infant and maternal urine at 1 month of infant’s age
Arsenic and Arsenic species Mother Infant
N Median, in μg/L
(10th-90th percentiles)
Range: min – max,
in μg/L
N Median, in μg/L
(10th-90th percentiles)
Range: min – max,
in μg/L
Total arsenic 11 78 (24–218) 1-224 12 4 (2–29) 1-41
Arsenite (AsIII) 10 4.6 (2.3 – 25.7) 2.06 – 25.9 6 0.71 (0.09 – 15.4) 0.09 -15.4
Arsenate (AsV) 11 2.05 (1.16 – 5.78) 0.32 – 15.7 6 1.37 (0.48 – 3.07) 0.48 – 3.07
Monomethyl Arsonic Acid (MMA) 10 11.64 (2.82 – 47.65) 2.46 – 65.5 10 0.41 (0.10 – 3.97) 0.10 – 4.23
Dimethyl Arsinic Acid (DMA) 11 51 (14.8 – 152) 0.351 – 158 12 3.2 (1.32 – 18.3) 1.29 – 19.8
Arsenobetaine 6 0.76 (0.18 – 5.7) 0.064- 6.21 6 0.20 (0.09 – 0.48) 0.09 – 0.48
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urinary arsenic content in the households with ≥50 μg/L of
arsenic in their drinking water, we modelled simple linear
regression to see whether the decline was significant be-
tween hosuehold’s drinking water arsenic categories. As ex-
pected, we did not find any difference since the households
might have changed their source of drinking water from
the point of household’s drinking water sample collection
to urine sampling.
Discussion
This study primarily demonstrates a low median arsenic
content in breast milk at 1, 6 and 9 months, despite high
arsenic exposure via drinking water. About 69%, 56% and
74% of breast milk samples contained arsenic concentra-
tion at the level of 0.5 μg/L at 1, 6 and 9 months of infant’s
age, respectively, while about 80% of the breast milk sam-
ples contained arsenic ≤1 μg/L at each time point. Mater-
nal and infant urine contained high amount of arsenic
irrespective of their drinking water arsenic exposure cat-
egories. Inorganic and methylated arsenic are the major
constituents of total urinary arsenic in both mother and
infant and dimethyl arsinic acid is the predominant spe-
cies. Arsenic excretion in breast milk did not show any as-
sociation with parents’ education, occupation and the
household’s socio-economic status. There was no correl-
ation between arsenic in breast milk and maternal or in-
fant urine at any time point.Table 5 Speciation and quantification of arsenic in infant and
Arsenic and Arsenic species Mother




Total arsenic 12 50.5 (20 – 87) 14 - 9
Arsenite (AsIII) 12 4.97 (2.74 – 11.6) 0.697
Arsenate (AsV) 12 1.26 (0.65 – 7.09) 0.517
Monomethyl Arsonic Acid (MMA) 12 7.41 (2.44 – 11.6) 0.836
Dimethyl Arsinic Acid (DMA 12 34.65 (14.8 – 63.9) 11.7
Arsenobetaine 10 0.46 (0.11 – 1.77) 0.096Information on low excretion of arsenic in breast milk
has been reported previously, although there is still a
scarcity of adequate data. Maternal exposure to high ar-
senic did not translate into passing significant amount of
inorganic arsenic in breast milk [23]. One study reported
that breast milk in the first 3 months of lactation con-
tained arsenic within the normal safety limit [24]. Other
studies claimed a protective effect of breastfeeding as ar-
senic excretion via breast milk was very low or below
the level of quantification and mostly of the trivalent form
of inorganic arsenic [3,7,25]. Also, a recent Taiwanese
study demonstrated similar findings and recommended
encouragement of breastfeeding [26]. Our study con-
curs that arsenic content in breast milk at each time
point of collection (1, 6 and 9 months) is low and de-
clines over time.
Contrary to the low arsenic concentration in breast
milk, urinary arsenic in these infants at exclusively
breastfeeding age (0–6 month) was relatively high. Urin-
ary arsenic concentrations depend on many other ex-
ogenous factors, such as arsenic content in drinking
water, amount of water consumption, arsenic exposure
from multiple sources and duration between exposure to
arsenic and collection of urine samples as 60-75% of
ingested arsenic is excreted in 3 days via urine [27,28].
We observed very high DMA constituents in infant’s
urine compared to MMA at 1 and 6 months of child’s
age (Tables 2 and 3) and these findings are quite similarmaternal urine at 6 months of child’s age
Infant
e: min – max,
/L
N Median, in μg/L
(10th-90th percentiles)
Range: min – max,
in μg/L
3 12 16.5 (3–27) 2 - 28
– 24.6 10 1.61 (0.34 – 3.72) 0.33 – 3.8
– 10.7 12 0.40 (0.14 – 1.36) 0.12 – 3.07
– 13.1 12 0.99 (0.31 – 3.01) 0.13 – 3.42
– 66.6 12 12.75 (2.1 – 19.7) 1.25 – 20.2
– 2.21 10 0.24 (0.09 – 5.08) 0.06 – 6.34
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et al. also reported similar findings of high DMA and low
MMA in urine of new born babies in the Andes,
Argentina and this was consequent to transfer of DMA to
foetus by the mother as a result of an efficient arsenic
methylation at later stage of pregnancy [15]. In response
to the foetal demand of choline for the development of
their brain, new synthesis of choline by phosphatidyleta-
nolamine methyltransferase occurred, subsequently
causing an efficient arsenic methylation in later preg-
nancy [29]. In the case of low folate intake, folate-linked
remethylation of homocystine for its removal from body
does not occur and removal of homocystine is a prerequis-
ite for an efficient one carbon metabolism of arsenic
methylation, and endogenous production of choline is the
only alternate for arsenic methylation in folate deficient
people [30]. In this study we did not collect data on mater-
nal or foetal folate intake although it was likely that the
study population was deficient in folate [31]; therefore the
alternate pathway i.e. endogenous production of choline,
might be the predominant route of arsenic methylation in
the study population and subsequently an increased meth-
ylated arsenic content was measured in both maternal and
children urine. Higher urinary arsenic in children indi-
cates additional means of arsenic exposure other than
breastfeeding and the mechanism of arsenic excretion
in breast milk might be different from excretion via
urine [17]. High excretion of methylated arsenic via
urine in children is induced by high amount of choline
and folate content in mature breast milk in the first few
postpartum months [32,33].
We surmise that the relatively high urinary arsenic in
infants is related to the intake of food and drink other
than breast milk. We are doing further work involving
deuterium oxide (D2O) dose to mother studies [20] to
explore this hypothesis. Besides, it is not possible to
completely rule out the chances of urine sample con-
tamination with arsenic polluted water that are used for
bathing and cleaning the children, although the effect of
such contamination is likely to be very smaller; for ex-
ample, if 10 ml of urine is contaminated with 0.1 ml of
water with 500 μg As/L concentration, there is a chance
of increasing the concentrations by 5 μg/L only [7].
In our study, water arsenic concentration was used to
characterise arsenic exposure, although the level of ex-
posure might have changed in the households following
our advice on not using any tubewell water that were
marked with ‘red colour’ (tubewell marked with red colour
when this contains ≥50 μg of arsenic per litre of water) at
the time of initial recruitment of participants. Therefore
the water arsenic exposure category for ≥50 μg/L might
not reflect the actual consumption over the successive
period of the study thus in the biological sample analysis.
As expected, we did not find any difference in maternalurinary arsenic levels by arsenic exposure categories in this
study. Urinary arsenic levels are good indicators for recent
exposure therefore, differences in maternal urinary arsenic
level by arsenic exposure categories are not likely to be the
effect of changing drinking water sources. However, we do
not have data on how many households changed their
source of drinking water during the study period and the
urinary arsenic levels presented here are unadjusted by
creatinine thus implying potential limitation. Further limi-
tation includes smaller sample size and not using other
samples such as nail, hair, blood or skin for arsenic detec-
tion. In contrary, urinary arsenic speciation and collection
of infants urine using PUC are the strengths of this study.
In this study, we observed no correlation between ar-
senic in breast milk and infant urine. Concha G et al.,
observed a similar findings [23]. We found a low con-
centration of arsenic passing in breast milk even in those
who passed high arsenic in their urine, although arsenic
transport mechanism through breast milk is not fully
understood. Breast milk contains low arsenic concentra-
tion and this may be due to an efficient maternal methy-
lation of inorganic arsenic [7]. Arsenic in trivalent form
(AsIII), mainly passes through breast milk and possibly
is the only arsenic metabolite that is protonated at
physiologic pH (pKa1 of arsenous acid = 9.2), via a trans-
porter called aquaglyceroporins, which transports AsIII
in most organisms [7,34,35] and found in rat mammary
gland during lactation [36]. One study indicated that ar-
senic excretion in breast milk varied greatly by individ-
ual and therefore breast milk values did not cluster with
values from water or other biological samples [17]. Like-
wise, despite high exposure, low arsenic concentration in
breast milk indicates that mammary gland acts as an ef-
fective filter that limits excretion of arsenic via breast
milk. The concentrations seems to be much lower than
World Health Organization’s maximum permissible limit
(WHO Permissible Limit 15 μg/kg-bw/week) [37].
Conclusions
Arsenic in breast milk was very low in women living in
arsenic contaminated areas. Breast milk arsenic did not
correlate with infants’ urinary arsenic, likely because of
supplemental feeding from other sources. Our data sup-
port the recommendation that breastfeeding is safe for
infants living in arsenic contaminated areas.
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